Asset Details
Do you wish to reserve the book?
Kcnn4 is a modifier gene of intestinal cystic fibrosis preventing lethality in the Cftr-F508del mouse
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Kcnn4 is a modifier gene of intestinal cystic fibrosis preventing lethality in the Cftr-F508del mouse
Do you wish to request the book?
Kcnn4 is a modifier gene of intestinal cystic fibrosis preventing lethality in the Cftr-F508del mouse
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Kcnn4 is a modifier gene of intestinal cystic fibrosis preventing lethality in the Cftr-F508del mouse
2018
Overview
Nearly 70% of cystic fibrosis (CF) patients bear the phenylalanine-508 deletion but disease severity differs greatly, and is not explained by the existence of different mutations in compound heterozygous. Studies demonstrated that genes other than
CFTR
relate to intestinal disease in humans and CF-mouse.
Kcnn4
, the gene encoding the calcium-activated potassium channel K
Ca
3.1, important for intestinal secretion, is present in a locus linked with occurrence of intestinal CF-disease in mice and humans. We reasoned that it might be a CF-modifier gene and bred a CF-mouse with
Kcnn4
silencing, finding that lethality was almost abolished. Silencing of
Kcnn4
did not improve intestinal secretory functions, but rather corrected increased circulating TNF-α level and reduced intestinal mast cell increase. Given the importance of mast cells in intestinal disease additional double mutant CF-animals were tested, one lacking mast cells (
C-kit
W-sh/W-sh
) and
Stat6
−/−
to block IgE production. While mast cell depletion had no effect, silencing
Stat6
significantly reduced lethality. Our results show that
Kcnn4
is an intestinal CF modifier gene partially acting through a STAT6-dependent mechanism.
Publisher
Nature Publishing Group UK,Nature Publishing Group
Subject
/ 631/443
/ Animals
/ Calcium
/ Cystic Fibrosis Transmembrane Conductance Regulator - genetics
/ Humanities and Social Sciences
/ Immunoglobulin E - metabolism
/ Inflammation Mediators - metabolism
/ Intermediate-Conductance Calcium-Activated Potassium Channels - deficiency
/ Intermediate-Conductance Calcium-Activated Potassium Channels - genetics
/ Intestinal Diseases - genetics
/ Intestinal Mucosa - pathology
/ Potassium channels (calcium-gated)
/ Science
